Skip to main content

Table 1 Demographic and clinical features among the neonates with ABO hemolytic disease (ABO HDN) in UGT1A1 c. 211 G > A mutation group VS c.211 normal group (N = 69)

From: UGT1A1 mutation association with increased bilirubin levels and severity of unconjugated hyperbilirubinemia in ABO incompatible newborns of China

 

c.211 mutation/ABO HDN

c.211 normal /ABO HDN

P

Sex

  

NS

Male

6(30.0)

25(51.0)

 

Female

14(70.0)

24(49.0)

 

Gestational week

39.4 ± 0.2

39.2 ± 0.1

NS

Birth weight (kg)

3.3 ± 0.08

3.2 ± 0.06

NS

Peak serum bilirubin levels (umol/L)

TBIL

404(219–556)

315(146–585)

0.028

IBIL

380(201–528)

303(129–552)

0.037

DBIL

14 (5.0–69)

12(3–35)

NS

Feeding

  

NS

Breast fed

3(15.0)

11(22.4)

 

Breast and formula

2(10.0)

9(18.4)

 

Formula

14(70.0)

20(40.8)

 

Unknown

1(5.0)

9(18.4)

 

Delivery method

  

NS

Vaginal

7(35.0)

27(55.1)

 

Cesarean

13(65.0)

22(44.9)

 
  1. Data are presented as n (%), mean standard deviation, or median (95% Confidence Interval)
  2. NS: no significance